Recent news on Fortical

Unigene Announces Strong Increase in Revenue and Improved ...  -  May 11, 2007
Genetic Engineering News (press release),Fortical royalties for the three months ended March 31, 2007 increased to $1845000 from $198000 for the three months ended March 31, 2006.

FDA to Biotech Investors: Relax, You Have Years Before Competition ...  -  Mar 27, 2007
Patent Baristas,Hydase (hyaluronidase), Fortical (calcitonin salmon recombinant) Nasal Spray, Amphadase (hyaluronidase), GlucaGen (glucagon recombinant for injection),

FDA Chief: Biogenerics will be Similar, Not Interchangeable  -  27 Mar 2007
Patent Baristas,Hylenex (hyaluronidase recombinant human), Hydase and Amphadase (hyaluronidase), and Fortical (calcitonin salmon recombinant) Nasal Spray.

Unigene Announces Financial Results for Fourth Quarter and Year ...  -  Mar 19, 2007
Genetic Engineering News (press release),Revenue for all periods is primarily due to Fortical. Revenue from Fortical sales and royalties were $3217000 for the three months ended December 31, 2006,

Unigene’s Site-Directed Bone Growth Technology May Have Multiple ...  -  Mar 20, 2007
Business Wire (press release),Fortical ® , Unigene’s nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005.

Health checkup: osteoporosis  -  Feb 28, 2007
Rochester Democrat and Chronicle,...hormonelike agents (Evista), and a nose spray (Miacalcin, Fortical). This category of medications can be very effective in preventing bone loss.

Unigene Receives Phase II SBIR Grant for Novel Peptide Discovery ...  -  Feb 15, 2007
dBusinessNews New York (press release),Fortical(R), Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005.

Unigene Engages University Clinicians to Advise on Bone Growth Program  -  Nov 30, 2006
dBusinessNews New York (press release),Fortical®, Unigene’s nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional